| The production facilities
of Serum Institute have the best in terms of equipment and human resources; essential
to ensure high quality vaccines. The manufacturing facilities conform to WHO current
Good Manufacturing Practice (cGMP) requirements and are approved by WHO, Geneva.
The unique large bioreactors for DTP group of vaccines have a huge batch size
to produce millions of doses.
The company also produces hundreds of millions
of doses of the Measles, Mumps and Rubella group of vaccines annually. Serum Institute
meets 100 % requirements for Measles vaccine of the Government of India and also
the global requirements..
An interesting in-built mechanism of continuous
improvement is by practicing the concept of Quality Circles. It empowers and encourages
the employees at the grass-root level and at the same time brings about upgradation
of quality of all fronts. The case studies of our Quality Circles have won many
awards not only at State and national levels but also at the International Level. It
goes without saying that Serum Institute's work ethic ensures that every safeguard
is instituted, every norm of cGMP is scrupulously observed, and every procedure
followed. Among the latest acquisitions is the state-of-the-art EDP system, which
provides instant information on every aspect of production, from stocks, inventory,
quantity of vaccines in the pipeline, Q.C. results of each batch, to sales, product
despatch and destinations.
|
